Evoke Pharma Inc.

10/17/2024 | Press release | Distributed by Public on 10/17/2024 14:15

Material Agreement Form 8 K

Item 1.01 Entry into a Material Definitive Agreement.

On October 16, 2024, Evoke Pharma, Inc. (the "Company") entered into the Seventh Amendment to Lease (the "Seventh Amendment") with SB Corporate Centre III-IV, LLC (the "Landlord"), to amend the Office Lease Agreement, dated as of December 19, 2016, by and between the Landlord and the Company (as amended, the "Lease"), relating to office space located at 420 Stevens Avenue, Suite 230, Solana Beach, California 92075, which serves as the Company's headquarters. The Seventh Amendment extends the term of the Lease from October 31, 2024 to March 31, 2027. The Seventh Amendment provides that the base monthly rent for the leased space will be $6,456.95 from November 1, 2024 to October 31, 2025, $6,650.66 from November 1, 2025 to October 31, 2026 and $6,850.18 from November 1, 2026 to March 31, 2027, and that the Company will be obligated to pay a specified percentage of certain expenses paid by the Landlord. The Company will also be granted a one-month rent abatement for November 2024, provided there is no material default under the Lease.

The foregoing description of the Seventh Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Seventh Amendment, which will be filed as an exhibit to the Company's Form 10-K to be filed for the year ended December 31, 2024.